EUVIMEDEUVIMED entdecken
Crossref

Machine learning‐guided design of potent darunavir analogs targeting HIV ‐1 proteases: A computational approach for antiretroviral drug discovery

Hathaichanok Chuntakaruk iD, Kajjana Boonpalit, Jiramet Kinchagawat, Fahsai Nakarin, Tanatorn Khotavivattana, Chanat Aonbangkhen, Yasuteru Shigeta, Kowit Hengphasatporn, Sarana Nutanong, Thanyada Rungrotmongkol, Supot Hannongbua

Journal of Computational Chemistry · 2024

DOI: 10.1002/jcc.27298 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Computational Chemistry, 2024. Verfasst von Hathaichanok Chuntakaruk und 10 weiteren Autor:innen. Beteiligte Einrichtung: Program in Bioinformatics and Computational Biology, Graduate School, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: HIV-1, HIV Protease Inhibitors, HIV Infections. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 96 Literaturangaben. Gefördert von: Thailand Science research and Innovation Fund Chulalongkorn University (CU), The 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund), The Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan through the Grant-in-Aid for Innovative Research "Mesohierarchy".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the pursuit of novel antiretroviral therapies for human immunodeficiency virus type‐1 (HIV‐1) proteases (PRs), recent improvements in drug discovery have embraced machine learning (ML) techniques to guide the design process. This study employs ensemble learning models to identify crucial substructures as significant features for drug development. Using molecular docking techniques, a collection of 160 darunavir (DRV) analogs was designed based on these key substructures and subsequently screened using molecular docking techniques. Chemical structures with high fitness scores were selected, combined, and one‐dimensional (1D) screening based on beyond Lipinski's rule of five (bRo5) and ADME (absorption, distribution, metabolism, and excretion) prediction implemented in the Combined Analog generator Tool (CAT) program. A total of 473 screened analogs were subjected to docking analysis through convolutional neural networks scoring function against both the wild‐type (WT) and 12 major mutated PRs. DRV analogs with negative changes in binding free energy () compared to DRV could be categorized into four attractive groups based on their interactions with the majority of vital PRs. The analysis of interaction profiles revealed that potent designed analogs, targeting both WT and mutant PRs, exhibited interactions with common key amino acid residues. This observation further confirms that the ML model‐guided approach effectively identified the substructures that play a crucial role in potent analogs. It is expected to function as a powerful computational tool, offering valuable guidance in the identification of chemical substructures for synthesis and subsequent experimental testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV Protease InhibitorsHIV InfectionsHumansDarunavirPeptide HydrolasesMolecular Docking SimulationHIV ProteaseDrug Discovery

Stichwörter der Autor:innen

darunavirensemble learning modelhuman immunodeficiency virus type‐1 proteaseimportant featureinteraction profile

Substanzen

DarunavirHIV Protease InhibitorsPeptide HydrolasesHIV Protease

Autor:innen und Institutionen

  • Program in Bioinformatics and Computational Biology, Graduate School, Chulalongkorn University, Bangkok, Thailand.
  • Department of Biochemistry, Faculty of Science, Center of Excellence in Structural and Computational Biology, Chulalongkorn University, Bangkok, Thailand.
  • School of Information Science and Technology, Vidyasirimedhi Institute of Science and Technology (VISTEC), Rayong, Thailand.
  • Center of Excellence in Natural Products Chemistry (CENP), Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
  • Center for Computational Sciences, University of Tsukuba, Ibaraki, Japan.
  • Department of Chemistry, Faculty of Science, Center of Excellence in Computational Chemistry (CECC), Chulalongkorn University, Bangkok, Thailand.

ORCID-Profile: Hathaichanok Chuntakaruk

Förderung

  • Thailand Science research and Innovation Fund Chulalongkorn University (CU)
  • The 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)
  • The Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan through the Grant-in-Aid for Innovative Research "Mesohierarchy"
  • Japan Agency for Science and Technology (JST) through the CREST program "Precise Arrangement Toward Functionality"

Zitieren

APA

Chuntakaruk, H., Boonpalit, K., Kinchagawat, J., Nakarin, F., Khotavivattana, T., Aonbangkhen, C., Shigeta, Y., Hengphasatporn, K., Nutanong, S., Rungrotmongkol, T., & Hannongbua, S. (2024). Machine learning‐guided design of potent darunavir analogs targeting HIV ‐1 proteases: A computational approach for antiretroviral drug discovery. Journal of Computational Chemistry. https://doi.org/10.1002/jcc.27298

Vancouver

Chuntakaruk H, Boonpalit K, Kinchagawat J, Nakarin F, Khotavivattana T, Aonbangkhen C, et al. Machine learning‐guided design of potent darunavir analogs targeting HIV ‐1 proteases: A computational approach for antiretroviral drug discovery. Journal of Computational Chemistry. 2024. doi:10.1002/jcc.27298

BibTeX
@article{Chuntakaruk2024,
  author = {Chuntakaruk, Hathaichanok and Boonpalit, Kajjana and Kinchagawat, Jiramet and Nakarin, Fahsai and Khotavivattana, Tanatorn and Aonbangkhen, Chanat and Shigeta, Yasuteru and Hengphasatporn, Kowit and Nutanong, Sarana and Rungrotmongkol, Thanyada and Hannongbua, Supot},
  title = {Machine learning‐guided design of potent darunavir analogs targeting HIV ‐1 proteases: A computational approach for antiretroviral drug discovery},
  journal = {Journal of Computational Chemistry},
  year = {2024},
  doi = {10.1002/jcc.27298}
}
Kostenlos starten →